Q2 2019

Filed Oct 11, 2019 · 10-Q · 41 days after period end · 0001193805-19-001331

Q2 2019 · 10-Q

Revenue

$0.00

— vs Q2 2018

Net Income

-$35.00K

N/M vs Q2 2018

EPS Diluted

-$0.03

N/M vs Q2 2018

Operating Income-$8,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2019	Q2 2018	Q2 2017	Q2 2016
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$35.00K	-$37.00K	-$43.00K	-$32.00K
EPS Diluted	-$0.03	-$0.03	-$0.03	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR